Skip to content

On June 19, 2012, AstraZeneca PLC completed its acquisition of Ardea Biosciences, Inc. Upon completion of the merger, Ardea became a wholly owned subsidiary of AstraZeneca. The total transaction value was approximately $1.26 billion. See Ardea's public filings with the Securities and Exchange Commission for more information.


AstraZeneca

Warning: error_log(/tmp/ardeabio.com.log): failed to open stream: Read-only file system in /home/pwp3/ardeabio/home/ardeabio.com/include/conf/ExtuiConfig.inc on line 50 Warning: error_log(/tmp/ardeabio.com.log): failed to open stream: Read-only file system in /home/pwp3/ardeabio/home/ardeabio.com/include/conf/ExtuiConfig.inc on line 50